LINDA PEARSON: Open Payments
NPI 1821314576 · SHENANDOAH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,290 in 46 payments from 17 companies in 2025. Trend: 2023 $1,488 · 2024 $2,267 · 2025 $1,290
Food & beverage: $1,290
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $220 |
| UCB, Inc. | 7 | $201 |
| Globus Medical, Inc. | 1 | $147 |
| SPR Therapeutics, Inc | 3 | $123 |
| Novartis Pharmaceuticals Corporation | 5 | $101 |
| TerSera Therapeutics LLC | 3 | $87 |
| Eisai Inc. | 2 | $65 |
| Boston Scientific Corporation | 3 | $64 |
| Medtronic, Inc. | 3 | $61 |
| Alexion Pharmaceuticals, Inc. | 2 | $60 |
Products named: EXCELSIUS GPS, BOTOX, SPRINT PNS System, KESIMPTA, QULIPTA, Prialt, Briviact, Nayzilam.
Industry payments across TX — which companies pay providers there.
